[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100229382":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":10,"locations":10,"responsibleParty":19,"collaborators":21,"id":24,"slug":25,"hasResults":26,"nctId":27,"briefTitle":28,"officialTitle":28,"acronym":10,"eligibilityCriteria":29,"healthyVolunteers":26,"sex":30,"minAge":31,"maxAge":10,"enrollmentInfo":32,"targetDuration":10,"studyType":35,"phases":10,"briefSummary":36,"conditions":37,"keywords":39,"overallStatus":44,"whyStopped":10,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":49,"completionDateStruct":51,"leadSponsor":53,"locationsCount":10},{"fullName":5,"class":6},"Affiliated Hospital to Academy of Military Medical Sciences","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"Postmenopausal group",null,"Patients at the age ≥ 60 years with more than one year of menopause, or patients having undergone bilateral oophorectomy.",{"label":13,"type":10,"description":14,"interventionNames":10},"Premenopausal group","Patients with regular menses during recent 3 months and having never received luteinizing hormone-releasing hormone analogue therapy.",[16],{"name":17,"affiliation":5,"role":18},"Santai Song","PRINCIPAL_INVESTIGATOR",{"type":20,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[22],{"name":23,"class":6},"Chinese Anti-Cancer Association","100229382","investigation-of-sex-hormone-levels-in-chinese-women-with-invasive-breast-cancer-100229382",false,"NCT02263846","Investigation of Sex Hormone Levels in Chinese Women With Invasive Breast Cancer","Inclusion Criteria:\n\n* Invasive breast cancer patients confirmed through pathology.\n* For postmenopausal group: patients at the age ≥ 60 years with more than one year of menopause, or patients having undergone bilateral oophorectomy.\n* For premenopausal group: patients with regular menses during recent 3 months and having never received luteinizing hormone-releasing hormone (LHRH) analogue therapy.\n* Patients who meet the above criteria can be enrolled whether they have received anti-cancer treatment or not.\n\nExclusion Criteria:\n\n* patients less than 60 years old who are amenorrhoeic but have not received bilateral oophorectomy or medical castration.","FEMALE","20 Years",{"count":33,"type":34},1183,"ACTUAL","OBSERVATIONAL","This study is to investigate sex hormones levels of Chinese patients with invasive breast cancer.The aim is to analyze biochemical monitoring results of premenopausal and postmenopausal patients to facilitate determination of menopausal status and propose clinical application.",[38],"Breast Cancer",[40,41,42,43],"Breast cancer","Menopause","Estradiol","Follicle stimulating hormone","COMPLETED","2015-04-09",{"date":47,"type":48},"2015-04-13","ESTIMATED",{"date":50,"type":10},"2011-11",{"date":52,"type":34},"2013-07",{"name":5,"class":6}]